My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 69

1.

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy.

Distefano G.

Ital J Pediatr. 2009 Nov 20;35(1):37.PMID: 19930562 [PubMed - in process]Related articlesFree article

2.

New developments in anthracycline-induced cardiotoxicity.

Mordente A, Meucci E, Silvestrini A, Martorana GE, Giardina B.

Curr Med Chem. 2009;16(13):1656-72. Review.PMID: 19442138 [PubMed - indexed for MEDLINE]Related articles

3.

Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron.

Simůnek T, Stérba M, Popelová O, Adamcová M, Hrdina R, Gersl V.

Pharmacol Rep. 2009 Jan-Feb;61(1):154-71. Review.PMID: 19307704 [PubMed - indexed for MEDLINE]Related articlesFree article

4.

[Severe heart failure in consequence of late anthracycline-induced cardiotoxicity--case report]

Urbanová D, Bubanská E, Hrebík M, Mladosievicová B.

Klin Onkol. 2009;22(1):34-7. Slovak. PMID: 19534438 [PubMed - indexed for MEDLINE]Related articles

5.

Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.

Popelová O, Sterba M, Hasková P, Simůnek T, Hroch M, Guncová I, Nachtigal P, Adamcová M, Gersl V, Mazurová Y.

Br J Cancer. 2009 Sep 1;101(5):792-802. Epub 2009 Jul 21.PMID: 19623174 [PubMed - indexed for MEDLINE]Related articles

6.

Anthracycline-induced cardiomyopathy.

Simmons A, Vacek JL, Meyers D.

Postgrad Med. 2008 Nov;120(4):67-72. Review.PMID: 19020367 [PubMed - indexed for MEDLINE]Related articles

7.

Molecular biology of doxorubicin-induced cardiomyopathy.

Umlauf J, Horký M.

Exp Clin Cardiol. 2002 Spring;7(1):35-9.PMID: 19644577 [PubMed - in process]Related articlesFree article

8.

Doxorubicinolone formation and efflux: a salvage pathway against epirubicin accumulation in human heart.

Salvatorelli E, Menna P, Lusini M, Covino E, Minotti G.

J Pharmacol Exp Ther. 2009 Apr;329(1):175-84. Epub 2009 Jan 14.PMID: 19144686 [PubMed - indexed for MEDLINE]Related articles

9.

Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood.

Rajić V, Aplenc R, Debeljak M, Prestor VV, Karas-Kuzelicki N, Mlinaric-Rascan I, Jazbec J.

Leuk Lymphoma. 2009 Oct;50(10):1693-8.PMID: 19863340 [PubMed - in process]Related articles

10.

The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy.

Mobini R, Andersson B.

Future Cardiol. 2005 Sep;1(5):675-82.PMID: 19804107 [PubMed - in process]Related articles

11.

Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure.

Ikeda U, Kasai H, Izawa A, Koyama J, Yazaki Y, Takahashi M, Higuchi M, Koh CS, Yamamoto K.

Curr Cardiol Rev. 2008 Aug;4(3):219-22.PMID: 19936198 [PubMed - in process]Related articlesFree article

12.

Pycnogenol((R)) improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats.

Klimas J, Kmecova J, Jankyova S, Yaghi D, Priesolova E, Kyselova Z, Musil P, Ochodnicky P, Krenek P, Kyselovic J, Matyas S.

Phytother Res. 2009 Dec 2. [Epub ahead of print]PMID: 19957251 [PubMed - as supplied by publisher]Related articles

13.

New Investigational Drugs for the Management of Acute Heart Failure Syndromes.

Tamarg J, Amorós I, Barana A, Caballero R, Delpón E.

Curr Med Chem. 2009 Dec 17. [Epub ahead of print]PMID: 20015042 [PubMed - as supplied by publisher]Related articles

14.

Medicinal Chemistry of Drugs used in Diabetic Cardiomyopathy.

Adeghate E, Kalasz H, Veress G, Teke K.

Curr Med Chem. 2009 Dec 17. [Epub ahead of print]PMID: 20015035 [PubMed - as supplied by publisher]Related articles

15.

Mechanisms of myocardial regeneration.

Hosoda T, Kajstura J, Leri A, Anversa P.

Circ J. 2010 Jan;74(1):13-7. Epub 2009 Nov 17.PMID: 19920358 [PubMed - in process]Related articlesFree article

16.

Increased expression of calcium-sensing receptors induced by ox-LDL amplifies apoptosis of cardiomyocytes during simulated ischaemia/reperfusion.

Guo J, Li HZ, Zhang WH, Wang LC, Wang LN, Zhang L, Li GW, Li HX, Yang BF, Wu L, Wang R, Xu CQ.

Clin Exp Pharmacol Physiol. 2009 Dec 23. [Epub ahead of print]PMID: 20039912 [PubMed - as supplied by publisher]Related articles

17.

Treatment of heart failure by calcium cycling gene therapy.

Lipskaia L, Ly H, Kawase Y, Hajjar RJ, Lompre AM.

Future Cardiol. 2007 Jul;3(4):413-23.PMID: 19804232 [PubMed - in process]Related articles

18.

Recovery from anthracycline cardiomyopathy--how can it be explained?

Christiansen S.

J Heart Lung Transplant. 2009 Jul;28(7):751. Epub 2009 May 6. No abstract available. PMID: 19560709 [PubMed - indexed for MEDLINE]Related articles

19.

The Roles of MicroRNAs in Heart Diseases: A Novel Important Regulator.

Cai B, Pan Z, Lu Y.

Curr Med Chem. 2009 Dec 17. [Epub ahead of print]PMID: 20015039 [PubMed - as supplied by publisher]Related articles

20.

Recent advances in the pathogenesis of syndromic autisms.

Benvenuto A, Manzi B, Alessandrelli R, Galasso C, Curatolo P.

Int J Pediatr. 2009;2009:198736. Epub 2009 Jun 21.PMID: 19946417 [PubMed - in process]Related articlesFree article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed
Write to the Help Desk